Preformulative assessment of preformed complexes of gemfibrozil, with cyclodextrins

PDA Journal of Pharmaceutical Science and Technology

Volumn 62, Issue 4, 2008, Pages 300-308

  Ain, Shabnam ^a   Philip, Betty ^a   Pathak, Kamla ^a  

^a Rajiv Academy for Pharmacy ^*  (India)

Author keywords

Cyclodextrins; Drug permeability; Gemfibrozil; Intrinsic dissolution rate; Microwave drying

Indexed keywords

ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN; CAVAMAX W6; CAVAMAX W7; CAVAMAX W8; GAMMA CYCLODEXTRIN; GEMFIBROZIL; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG PENETRATION; DRUG SOLUBILITY; EVAPORATION; FREEZE DRYING; INFRARED SPECTROSCOPY; METHODOLOGY; MICROWAVE DRYING; MICROWAVE RADIATION; PH; PRECIPITATION; PREFORMULATION; PRODUCT DEVELOPMENT; SCANNING ELECTRON MICROSCOPY; TRAY DRYING; X RAY DIFFRACTION;

ANIMALS; ANTILIPEMIC AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CYCLODEXTRINS; DESICCATION; DRUG STABILITY; FREEZE DRYING; GEMFIBROZIL; HYDROGEN-ION CONCENTRATION; INTESTINAL ABSORPTION; INTESTINES; MICROSCOPY, ELECTRON, SCANNING; MICROWAVES; PERMEABILITY; RATS; REPRODUCIBILITY OF RESULTS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE; X-RAY DIFFRACTION;

EID: 56849114001     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Saitoh, H.; Oda, M.; Kobayashi, M.; Aungst, B. J. β-cyclodextrin as a suitable solubilizing agent for in-situ absorption study of poorly water soluble drugs. Int. J. Pharm. 2000, 280, 95-102.
2. Al-Marzouqi, A. H.; Shehatta, I.; Jobe, B.; Towanda, A. Phase solubility and inclusion complex of itraconazole with β-cyclodextrin using supercritical carbon dioxide. J. Pharm. Sci. 2006, 95, 292-304.
3. Rowe, R. C.; Sheskey, P. J.; Owen, S. C. Handbook of Pharmaceutical Excipients; Publication Division of The Royal Pharmaceutical Society of Great Britain: London, 2006; pp 217-220.
4. Ahuja, A.; Challa, R.; Ali, J.; Khar, R. K. Cyclodextrin in drug delivery: An updated review. AAPS PharmSciTech 2005, 6 (2), E329-E357.
5. Loftsson, T.; Hreinsdottir, D.; Masson, M. Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 2005, 302, 18-28.
6. Sweetman, S. C. Martindale: The Complete Drug Reference, 33rd ed.; The Pharmaceutical Press: London, 2002; pp 896-897.
7. Drug Information Online. Available at http://www.drugs.com.
8. Block J. H.; Beale, J. M. Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry, 11th ed.; Lippincott Williams and Wilkins: New York, 2004; p 951.
9. Indian Pharmacopoeia; Controller of Publications: Delhi, India, 1996.
10. Dressman, J. B.; Lennernas, H. Oral drug absorption: Prediction and assessment. Marcel Dekker: New York, 2000; Vol. 106, pp 57-59.
11. Higuchi, T.; Connors, K. A. Phase solubility technique. Adv. Anal. Chem. Instrum. 1965, 4, 117-212.
12. Becket, G.; Schep, L. J.; Tan, M. Y. Improvement of in vitro dissolution of praziquantel by complexation with α, β- and γ- cyclodextrins. Int. J. Pharm. 1999, 179, 65-71.
13. Zingone, G.; Rubessa, F. Preformulation study of the inclusion complex warfarin-β-cyclodextrin. Int. J. Pharm. 2005, 291, 3-10.
14. Govindarajan, R.; Nagarsenkar, M. S. Influence of preparation methodology on solid-state properties of an acidic drug-cyclodextrin system. J. Pharm. Pharmacol. 2004, 56, 725-733.
15. Viegas, T. X.; Curatella, R. U.; Vanuinkle, L. L.; Brinker, G. Intrinsic drug dissolution testing using the stationary disk system. Dissolution Technologies 2001,8,1-4.
16. Aulton, M. E.; Pharmacetics: The Science of Dosage Form Design, 2nd ed.; Churchill Livingstone: New York, 2002; pp 119-123, 492-493.
17. Avdeef, A.; Berger, C. M.; Brownell, C. pH-metric solubility. 2. Correlation between the acid-base titration and the saturation shake-flask solubility-pH methods. Pharm. Res. 2000, 17, 85-89.
18. Ancel, H. C.; Allen, L. V.; Popovich, N. G. Pharmaceutical Dosage Forms and Drug Delivery Systems, 7th ed,; B. I. Publications. Pvt. Ltd.: 2000; p 75.
19. Bolton, S. Pharmaceutical Statistics. Practical and Clinical Applications, 3rd ed.; Marcel Dekker Inc., New York, 1997; Vol. 80, pp 591-623.
20. Szejtli, J. Past, present and future of cyclodextrin research. Pure. Appl. Chem. 2004, 76, 1825-1845.
21. Rao, V. M.; Haslam, J. L.; Stella, V. J. Controlled and complete release of a model poorly water soluble drug, prednisolone, from hydroxypropyl methyl cellulose matrix tablets using (SBE) 7m-β-cyclodextrin as a solubilizing agent. J. Pharm. Sci. 2001, 90, 807-816.
22. Veiga, F.; Fernandes, C.; Maincent, P. Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary system. Drug Dev. Ind. Pharm. 2001, 27, 523-532.
23. Reddy, M. N.; Rehana, T.; Ramakrishna, S.; Chowdary, K. P. R.; Diwan, P. V. β-cyclodextrin complexes of celecoxib: Molecular modeling, characterization and -dissolution studies. AAPS PharmSci. 2004, 6 (1), Article 7.
24. Arias, M. J.; Moyano, J. R.; Munoz, P.; Gines, J. M.; Justo, A.; Giordano, F. Study of omeprazole-γ-cyclodextrin complexation in the solid state. Drug Dev. Ind. Pharm. 2000, 26, 253-259.
25. Yong, C. S.; Choi, H. G.; Kim, D. D.; Jun, H. W.; Yoo, B. K. Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl β- -cyclodextrins. Drug Dev. Ind. Pharm. 2003, 29, 1085-1094.